Berry Street Capital Management LLP Biomarin Pharmaceutical Inc Transaction History

Berry Street Capital Management LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$74.28 - $92.69 $5.34 Million - $6.66 Million	-71,875 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$71.72 - $91.47 $1.12 Million - $1.43 Million	15,625 Added 27.78%	71,875 $6.35 Million
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $467,312 - $534,187	6,250 Added 12.5%	56,250 $4.35 Million
Q2 2021 Aug 13, 2021	BUY	$75.51 - $84.79 $943,875 - $1.06 Million	12,500 Added 33.33%	50,000 $4.17 Million
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $2.8 Million - $3.4 Million	37,500 New	37,500 $2.83 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Berry Street Capital Management LLP, based on Form 13F filings with the SEC.

Stay updated on Berry Street Capital Management LLP with notifications on news.